Shionogi taps Swedish partners for drug discovery effort
This article was originally published in Scrip
Shionogi has signed a memorandum of understanding with the Swedish government that is expected to lead to R&D collaborations with academic institutions and bioventure companies in the Scandinavian country.
You may also be interested in...
Pricing set somewhere down the middle as Moderna reaches deal with US government on initial supplies of its mRNA coronavirus vaccine.
Headquartered in both China and US, the new firm will help partners bring drugs to China and other Asian markets. Novavax licenses COVID-19 vaccine in Japan to Takeda, following previous week’s deal for the vaccine in India.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.